Vaxart receives Nasdaq delisting notice; trading suspended July 8, 2025

Vaxart, Inc.

Nasdaq Staff determined to delist VXRT common stock for failing to meet $1.00 minimum bid price requirement.
Trading will be suspended at open on July 8, 2025, despite planned hearing request.
Company expects to begin trading on OTC markets (ticker VXRT) on July 8, 2025, pending OTCQX approval.
Vaxart received prior notices on July 2, 2024, and Dec 31, 2024, regarding bid price non-compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.